{"title":"当激情不够时:传染病工作人员的减少。","authors":"Jennifer A Leeds","doi":"10.1128/msphere.00902-24","DOIUrl":null,"url":null,"abstract":"<p><p>Scientists and physicians who pursue careers in infectious diseases are often passionate about understanding microbial pathogenesis and anti-microbial resistance. They are driven by the impact that their work has on improving public health and reducing human suffering through the discovery, development, and delivery of technologies that enable prevention and radical cure of debilitating and deadly diseases. Yet, despite their passion, there is a shrinking talent pool in antibiotic research and development (R&D) (https://www.amrindustryalliance.org/mediaroom/leaving-the-lab-tracking-the-decline-in-amr-rd-professionals/) as well as in the clinical practice specialty of infectious diseases as recognized by the Infectious Diseases Society of America (https://www.idsociety.org/news--publications-new/articles/2024/idsa-and-pids-statement-on-2024-id-fellowship-match/). This talent drain has wide repercussions beyond its impact on R&D and clinical practice and needs to be addressed from many angles to attract and retain new talent, to increase investment in and output from antibiotic R&D, and to mitigate the rising risk of the inability to deliver safe and efficacious solutions to patients in need.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0090224"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12108070/pdf/","citationCount":"0","resultStr":"{\"title\":\"When passion is not enough: the waning of the infectious disease workforce.\",\"authors\":\"Jennifer A Leeds\",\"doi\":\"10.1128/msphere.00902-24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Scientists and physicians who pursue careers in infectious diseases are often passionate about understanding microbial pathogenesis and anti-microbial resistance. They are driven by the impact that their work has on improving public health and reducing human suffering through the discovery, development, and delivery of technologies that enable prevention and radical cure of debilitating and deadly diseases. Yet, despite their passion, there is a shrinking talent pool in antibiotic research and development (R&D) (https://www.amrindustryalliance.org/mediaroom/leaving-the-lab-tracking-the-decline-in-amr-rd-professionals/) as well as in the clinical practice specialty of infectious diseases as recognized by the Infectious Diseases Society of America (https://www.idsociety.org/news--publications-new/articles/2024/idsa-and-pids-statement-on-2024-id-fellowship-match/). This talent drain has wide repercussions beyond its impact on R&D and clinical practice and needs to be addressed from many angles to attract and retain new talent, to increase investment in and output from antibiotic R&D, and to mitigate the rising risk of the inability to deliver safe and efficacious solutions to patients in need.</p>\",\"PeriodicalId\":19052,\"journal\":{\"name\":\"mSphere\",\"volume\":\" \",\"pages\":\"e0090224\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12108070/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"mSphere\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1128/msphere.00902-24\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"mSphere","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1128/msphere.00902-24","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
When passion is not enough: the waning of the infectious disease workforce.
Scientists and physicians who pursue careers in infectious diseases are often passionate about understanding microbial pathogenesis and anti-microbial resistance. They are driven by the impact that their work has on improving public health and reducing human suffering through the discovery, development, and delivery of technologies that enable prevention and radical cure of debilitating and deadly diseases. Yet, despite their passion, there is a shrinking talent pool in antibiotic research and development (R&D) (https://www.amrindustryalliance.org/mediaroom/leaving-the-lab-tracking-the-decline-in-amr-rd-professionals/) as well as in the clinical practice specialty of infectious diseases as recognized by the Infectious Diseases Society of America (https://www.idsociety.org/news--publications-new/articles/2024/idsa-and-pids-statement-on-2024-id-fellowship-match/). This talent drain has wide repercussions beyond its impact on R&D and clinical practice and needs to be addressed from many angles to attract and retain new talent, to increase investment in and output from antibiotic R&D, and to mitigate the rising risk of the inability to deliver safe and efficacious solutions to patients in need.
期刊介绍:
mSphere™ is a multi-disciplinary open-access journal that will focus on rapid publication of fundamental contributions to our understanding of microbiology. Its scope will reflect the immense range of fields within the microbial sciences, creating new opportunities for researchers to share findings that are transforming our understanding of human health and disease, ecosystems, neuroscience, agriculture, energy production, climate change, evolution, biogeochemical cycling, and food and drug production. Submissions will be encouraged of all high-quality work that makes fundamental contributions to our understanding of microbiology. mSphere™ will provide streamlined decisions, while carrying on ASM''s tradition for rigorous peer review.